Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary Hypertension
NCT ID: NCT03404492
Last Updated: 2023-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2018-06-12
2020-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
NCT02579954
Rehabilitation for Patients With Pulmonary Hypertension
NCT03955016
Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability
NCT06107452
RV Systolic and Diastolic Function and Contractile Reserve Under Acute Exercise and in Response to Chronic Exercise-based Rehabilitation
NCT04188756
Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure
NCT02524574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with pulmonary hypertension
Stress echocardiography
A stress echocardiography will be performed in addition to the traditional patient care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stress echocardiography
A stress echocardiography will be performed in addition to the traditional patient care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proven pulmonary hypertension: PAPm ≥ 25mmHg, known PH
* Group 1,3,4 or 5 of the pulmonary hypertension classification
* Clinical stability \> 1 month clinically determined by clinician
* NYHA II or III class
* Signature of informed consent form following appropriate information
* Patient affiliated to the Social Security System
Exclusion Criteria
* Complex congenital heart disease
* Acoustic window which does not allow the echocardiography to be performed correctly
* Permanent cardiac arrhythmia
* NYHA IV class and NYHA I class
* Inability to perform at least a minimal effort on an ergometer
* Unstabilized acute coronary syndrome
* Compensatory heart failure
* Disturbances of ventricular rhythm veins, may not be narrowed.
* Prevalence of high-risk embolic intracardiac thrombus
* Prevalence of high-risk embolic intracardiac thrombus
* Preference of a medium to high abundance peericard-like thinning.
* Venous thromboembolic venous thromboembolic disease (\> 3 months)
* Left ventricular ejector obstruction (severe and/or symptomatic)
* Persons under guardianship, under curatorship, protected by law
* Persons deprived of their liberty
* Pregnant and parturient women
* Major not able or unable to express consent
* Minors
* Inability to perform cardiac rehabilitation
* Modynamic instability
* Follow-up impossible for geographical or psychological reasons
* Inadequate command of the French language
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamela MOCERI, PH
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Pasteur
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-PP-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.